Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (621) Arrow Down
Filter Results: (621) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (621)
    • People  (2)
    • News  (57)
    • Research  (447)
    • Events  (2)
    • Multimedia  (9)
  • Faculty Publications  (391)

Show Results For

  • All HBS Web  (621)
    • People  (2)
    • News  (57)
    • Research  (447)
    • Events  (2)
    • Multimedia  (9)
  • Faculty Publications  (391)
← Page 24 of 621 Results →
  • April 2024 (Revised November 2024)
  • Case

Moderna: Pioneering a People Platform to Accelerate Science Innovation

By: Tatiana Sandino, Emil Dy and Samuel Grad
Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for the body to create antibodies. When Stéphane Bancel (HBS 2000) took over in 2011, he bet on the potential of this... View Details
Keywords: Disruptive Innovation; Talent and Talent Management; Selection and Staffing; AI and Machine Learning; Digital Strategy; Innovation and Management; Leadership Development; Management Practices and Processes; Management Systems; Organizational Culture; Performance Evaluation; Alignment; Employee Relationship Management; Science-Based Business; Expansion; Biotechnology Industry; Biotechnology Industry; United States
Citation
Educators
Purchase
Related
Sandino, Tatiana, Emil Dy, and Samuel Grad. "Moderna: Pioneering a People Platform to Accelerate Science Innovation." Harvard Business School Case 124-091, April 2024. (Revised November 2024.)
  • November 2020
  • Teaching Note

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details
Keywords: Mergers and Acquisitions; Valuation; Value; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Biotechnology Industry; Biotechnology Industry; United States
Citation
Purchase
Related
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Teaching Note 221-036, November 2020.
  • Spring 2014
  • Article

Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company

By: Andrew Knauer and George Serafeim
Faced with a large percentage of investors that chase short-term returns, companies could benefit by attracting investors with longer-term horizons and incentives that are more consistent with the long-term strategy of the company. The managers of most companies take... View Details
Keywords: Investing; Asset Management; Long-term Investing; Short-termism; Sustainability; Integrated Reporting; Leadership & Corporate Accountability; Pharmaceuticals; Leadership; Integrated Corporate Reporting; Investment; Business and Stakeholder Relations; Corporate Finance; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Purchase
Related
Knauer, Andrew, and George Serafeim. "Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company." Journal of Applied Corporate Finance 26, no. 2 (Spring 2014): 57–64.
  • 01 May 2009
  • Conference Presentation

The enabling and constraining effects of attention structures on entrepreneurial activity in the U.S. biodiesel industry

By: Shon R. Hiatt
Keywords: Entrepreneurship; Biotechnology Industry; Biotechnology Industry; United States
Citation
Related
Hiatt, Shon R. "The enabling and constraining effects of attention structures on entrepreneurial activity in the U.S. biodiesel industry." Paper presented at the Smith Entrepreneurship Research Conference, May 01, 2009.
  • February 2010
  • Background Note

Millipore Background Note

By: Elie Ofek and Natalie Kindred
This note provides background on Millipore Corporation, a global provider of products and services used primarily in the discovery, development and production of therapeutic drugs. With a track record of quickly adapting to the evolving needs of its customers,... View Details
Keywords: Organizational Change and Adaptation; Customer Focus and Relationships; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Related
Ofek, Elie, and Natalie Kindred. "Millipore Background Note." Harvard Business School Background Note 510-059, February 2010.
  • July 2009
  • Teaching Note

Khosla Ventures: Biofuels Strategy (TN)

By: Joseph B. Lassiter III
Teaching Note for [809004]. View Details
Keywords: Partners and Partnerships; Growth and Development; Financing and Loans; Investment; Emerging Markets; Renewable Energy; Biotechnology Industry; Biotechnology Industry; Singapore; Kuwait; China
Citation
Purchase
Related
Lassiter, Joseph B., III. "Khosla Ventures: Biofuels Strategy (TN)." Harvard Business School Teaching Note 810-015, July 2009.
  • March 2009
  • Teaching Note

Antegren: A Beacon of Hope (TN)

By: Joshua D. Margolis
Teaching Note for [408025], [408026], [408027], and [408028]. View Details
Keywords: Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Biotechnology Industry; Biotechnology Industry
Citation
Purchase
Related
Margolis, Joshua D. "Antegren: A Beacon of Hope (TN)." Harvard Business School Teaching Note 409-096, March 2009.
  • 2006
  • Chapter

BioRisk: interleukin-2 from laboratory to market in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Product Development; Risk and Uncertainty; Health Testing and Trials; Biotechnology Industry; Biotechnology Industry; United States; Germany
Citation
Related
Daemmrich, Arthur A. "BioRisk: interleukin-2 from laboratory to market in the United States and Germany ." In The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context, edited by Thomas Schlich and Ulrich Tröhler, 242–261. Routledge, 2006.
  • June 2003 (Revised October 2004)
  • Case

Novartis: The Challenge of Success (C)

By: Sandra J. Sucher and Stacy McManus
Supplements the (A) and (B) cases. View Details
Keywords: Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (C)." Harvard Business School Case 603-045, June 2003. (Revised October 2004.)
  • March 2002 (Revised May 2002)
  • Case

Genzyme: Engineering the Market for Orphan Drugs

Genzyme has made money with external technology in orphan drug markets generally considered to be too small to be attractive to other drug companies. Now competition is entering these same markets, placing Genzyme's business model under new pressures. View Details
Keywords: Business Model; Information Technology; Market Entry and Exit; Biotechnology Industry; Biotechnology Industry
Citation
Educators
Purchase
Related
Chesbrough, Henry W., and Clarissa Ceruti. "Genzyme: Engineering the Market for Orphan Drugs." Harvard Business School Case 602-147, March 2002. (Revised May 2002.)
  • September 2001
  • Supplement

Millennium Pharmaceuticals, Inc. (B)

By: Stefan H. Thomke and Ashok Nimgade
Supplements the (A) case. View Details
Keywords: Biotechnology Industry; Biotechnology Industry; Cambridge
Citation
Purchase
Related
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (B)." Harvard Business School Supplement 602-063, September 2001.
  • October 2000
  • Teaching Note

Kendle International Inc. TN

By: Dwight B. Crane and Indra Reinbergs
Teaching Note for (9-200-033). View Details
Keywords: Biotechnology Industry; Biotechnology Industry
Citation
Purchase
Related
Crane, Dwight B., and Indra Reinbergs. "Kendle International Inc. TN." Harvard Business School Teaching Note 201-014, October 2000.
  • September 1997
  • Case

Bayer AG (B)

By: John A. Quelch
Bayer's senior executives detail the communications challenge program that resulted from the company's reacquisition of its brand name and trademark cross, which gave Bayer one name worldwide for the first time since World War I. View Details
Keywords: Globalized Firms and Management; War; Acquisition; Trademarks; Brands and Branding; Communication Strategy; Biotechnology Industry; Biotechnology Industry; Germany
Citation
Educators
Purchase
Related
Quelch, John A., and Robin Root. "Bayer AG (B)." Harvard Business School Case 598-032, September 1997.
  • 2000
  • Chapter

In Search of Dynamic Capabilities: The Origins of R&D Competence in Biopharmaceuticals

By: Gary P. Pisano
Keywords: Competency and Skills; Research and Development; Biotechnology Industry; Biotechnology Industry
Citation
Find at Harvard
Related
Pisano, Gary P. "In Search of Dynamic Capabilities: The Origins of R&D Competence in Biopharmaceuticals." Chap. 5 in The Nature and Dynamics of Organizational Capabilities, edited by Giovanni Dosi, Richard Nelson, and Sidney Winter, 129–154. New York: Oxford University Press, 2000.
  • 22 Sep 2020
  • Research & Ideas

Recessions Push Some Entrepreneurs to Launch Too Soon

an associate professor at University of Lausanne, studied 3,025 US founders from 2005 to 2012 and their 1,747 startups in the biotechnology and medical device sectors during previous economic downturns. Their research was conducted before... View Details
Keywords: by Sean Silverthorne
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

challenges, not on the hard work of winning hearts and minds, Shapiro ultimately lost his company. He was forced to sell Monsanto to Pharmacia-Upjohn, which bought it for its pharmaceutical division, valuing the agricultural biotechnology... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • Aug 2011 - 2011
  • Conference Presentation

Institutional Heterogeneity, Innovation, and Entrepreneurship in the U.S. Biodiesel Fuel Sector

By: Shon R. Hiatt
Keywords: Innovation and Invention; Entrepreneurship; Business Ventures; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry
Citation
Related
Hiatt, Shon R. "Institutional Heterogeneity, Innovation, and Entrepreneurship in the U.S. Biodiesel Fuel Sector." Paper presented at the Academy of Management Annual Meeting, San Antonio, TX, August 2011.
  • 2011
  • Other Unpublished Work

From Farms to Fuel Tanks: Collective Actors and New-Venture Innovation in the U.S. Biodiesel Fuel Sector

By: Shon R. Hiatt
Little is known about the influence of collective actors on innovative technological recombinations by new ventures. Using data from U.S. biodiesel producers, I examine how the efforts of multiple collective actors (farm associations) to promote varying types of... View Details
Keywords: Alliances; Agribusiness; Energy Sources; Innovation and Invention; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
Citation
Related
Hiatt, Shon R. "From Farms to Fuel Tanks: Collective Actors and New-Venture Innovation in the U.S. Biodiesel Fuel Sector." 2011.
  • Profile

Terrance McGuire

and entrepreneur, during which time they have collaborated on a long list of successful biotechnology startups. “Bob Langer is passionate about improving peoples' lives,” McGuire said. “He was one of the early... View Details
  • 22 Nov 2016
  • First Look

November 22, 2016

commercial implications—the technology would be immensely important to biotechnology firms looking to develop gene therapy products and was, therefore, sure to generate strong revenues for whichever entity owned the IP—but would also... View Details
Keywords: Sean Silverthorne
  • ←
  • 24
  • 25
  • …
  • 31
  • 32
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.